Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400080426Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of lidocaine in Tonsillar hyperplasia and adenoidal hypertrophy (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: CSHQ score, Vital signs and 2 more. Planned start Jan 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400080426.